UBS Group’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
MI
UBS Group's GPAT Position: Q3 2026 in Review
UBS Group reduced its GP-Act III Acquisition Corp (GPAT) stake by 11% in Q3 2026, selling an estimated $22 and leaving 16 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #10780.
UBS Group first reported a position in GPAT in Q4 2024 and has held it in 8 quarters since. The position peaked at $118K in Q3 2025. 22 funds tracked by Wall St. Rank hold GPAT as of Q3 2026.
- UBS Group held 16 shares of GP-Act III Acquisition Corp worth $176 as of Q3 2026.
- UBS Group sold 2 GP-Act III Acquisition Corp shares in Q3 2026, an estimated $22.
- GP-Act III Acquisition Corp made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10780 holding.
- UBS Group first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 8 quarters since.
- UBS Group's GP-Act III Acquisition Corp position peaked at $118K in Q3 2025.
- 22 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.